Bodal Chemicals Future Growth
Future criteria checks 4/6
Bodal Chemicals is forecast to grow earnings and revenue by 98.1% and 14.3% per annum respectively. EPS is expected to grow by 98.8% per annum. Return on equity is forecast to be 7.1% in 3 years.
Key information
98.1%
Earnings growth rate
98.8%
EPS growth rate
Chemicals earnings growth | 22.7% |
Revenue growth rate | 14.3% |
Future return on equity | 7.1% |
Analyst coverage | Low |
Last updated | 15 Nov 2024 |
Recent future growth updates
Recent updates
We Think Shareholders May Want To Consider A Review Of Bodal Chemicals Limited's (NSE:BODALCHEM) CEO Compensation Package
Sep 18When Should You Buy Bodal Chemicals Limited (NSE:BODALCHEM)?
Apr 04Need To Know: This Analyst Just Made A Substantial Cut To Their Bodal Chemicals Limited (NSE:BODALCHEM) Estimates
Aug 18Increases to Bodal Chemicals Limited's (NSE:BODALCHEM) CEO Compensation Might Cool off for now
Sep 20Bodal Chemicals' (NSE:BODALCHEM) Dividend Will Be ₹0.80
Sep 04Is Bodal Chemicals (NSE:BODALCHEM) A Risky Investment?
Jul 23Is Bodal Chemicals (NSE:BODALCHEM) A Risky Investment?
Jan 13Bodal Chemicals (NSE:BODALCHEM) Has A Somewhat Strained Balance Sheet
Jul 18Should You Investigate Bodal Chemicals Limited (NSE:BODALCHEM) At ₹95.80?
Apr 08Bodal Chemicals Limited's (NSE:BODALCHEM) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?
Mar 21These 4 Measures Indicate That Bodal Chemicals (NSE:BODALCHEM) Is Using Debt Extensively
Mar 06How Is Bodal Chemicals' (NSE:BODALCHEM) CEO Compensated?
Feb 19Is Bodal Chemicals Limited (NSE:BODALCHEM) A Great Dividend Stock?
Feb 06What Percentage Of Bodal Chemicals Limited (NSE:BODALCHEM) Shares Do Insiders Own?
Jan 22Would Shareholders Who Purchased Bodal Chemicals' (NSE:BODALCHEM) Stock Three Years Be Happy With The Share price Today?
Jan 06Are Insiders Buying Bodal Chemicals Limited (NSE:BODALCHEM) Stock?
Dec 22Bodal Chemicals Limited (NSE:BODALCHEM) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
Dec 07Here's Why Bodal Chemicals (NSE:BODALCHEM) Has A Meaningful Debt Burden
Nov 22Is Bodal Chemicals Limited (NSE:BODALCHEM) A Strong Dividend Stock?
Nov 07Is Bodal Chemicals (NSE:BODALCHEM) Likely To Turn Things Around?
Oct 13What You Need To Know About Bodal Chemicals Limited's (NSE:BODALCHEM) Investor Composition
Sep 25Who Has Been Buying Bodal Chemicals Limited (NSE:BODALCHEM) Shares?
Sep 09If You Had Bought Bodal Chemicals (NSE:BODALCHEM) Stock Five Years Ago, You Could Pocket A 144% Gain Today
Aug 25Bodal Chemicals (NSE:BODALCHEM) Has A Somewhat Strained Balance Sheet
Aug 10What Did Bodal Chemicals' (NSE:BODALCHEM) CEO Take Home Last Year?
Aug 10Should Bodal Chemicals Limited (NSE:BODALCHEM) Be Part Of Your Income Portfolio?
Jul 29Bodal Chemicals Limited's (NSE:BODALCHEM) Shares May Have Run Too Fast Too Soon
Jul 14Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 22,803 | 934 | 730 | 1,721 | 1 |
3/31/2026 | 19,431 | 616 | 477 | 1,484 | 2 |
3/31/2025 | 17,399 | 39 | 620 | 1,388 | 1 |
9/30/2024 | 15,756 | 16 | 937 | 2,131 | N/A |
6/30/2024 | 14,841 | 31 | N/A | N/A | N/A |
3/31/2024 | 13,946 | 65 | -407 | 2,042 | N/A |
12/31/2023 | 13,906 | 72 | N/A | N/A | N/A |
9/30/2023 | 13,728 | 87 | -477 | 2,062 | N/A |
6/30/2023 | 14,440 | 177 | N/A | N/A | N/A |
3/31/2023 | 15,743 | 380 | -479 | 2,899 | N/A |
12/31/2022 | 17,678 | 676 | N/A | N/A | N/A |
9/30/2022 | 20,138 | 896 | -2,157 | 1,101 | N/A |
6/30/2022 | 20,878 | 1,030 | N/A | N/A | N/A |
3/31/2022 | 20,553 | 1,042 | -1,726 | -135 | N/A |
12/31/2021 | 18,861 | 1,004 | N/A | N/A | N/A |
9/30/2021 | 16,904 | 1,052 | -2,713 | -355 | N/A |
6/30/2021 | 15,304 | 916 | N/A | N/A | N/A |
3/31/2021 | 12,264 | 420 | -1,911 | -130 | N/A |
12/31/2020 | 11,622 | 418 | N/A | N/A | N/A |
9/30/2020 | 11,224 | 297 | 677 | 1,198 | N/A |
6/30/2020 | 11,204 | 406 | N/A | N/A | N/A |
3/31/2020 | 13,748 | 872 | -425 | 96 | N/A |
12/31/2019 | 13,506 | 941 | N/A | N/A | N/A |
9/30/2019 | 13,586 | 1,091 | -1,367 | 115 | N/A |
6/30/2019 | 14,441 | 1,323 | N/A | N/A | N/A |
3/31/2019 | 14,235 | 1,432 | 377 | 1,860 | N/A |
12/31/2018 | 13,725 | 1,528 | N/A | N/A | N/A |
9/30/2018 | 13,454 | 1,527 | N/A | N/A | N/A |
6/30/2018 | 12,083 | 1,321 | N/A | N/A | N/A |
3/31/2018 | 11,422 | 1,226 | N/A | 71 | N/A |
3/31/2017 | 12,344 | 1,329 | N/A | 1,036 | N/A |
3/31/2016 | 9,078 | 860 | N/A | 1,312 | N/A |
3/31/2015 | 10,443 | 918 | N/A | 1,977 | N/A |
3/31/2014 | 9,496 | 302 | N/A | 492 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BODALCHEM's forecast earnings growth (98.1% per year) is above the savings rate (6.7%).
Earnings vs Market: BODALCHEM's earnings (98.1% per year) are forecast to grow faster than the Indian market (18.1% per year).
High Growth Earnings: BODALCHEM's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: BODALCHEM's revenue (14.3% per year) is forecast to grow faster than the Indian market (10.6% per year).
High Growth Revenue: BODALCHEM's revenue (14.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: BODALCHEM's Return on Equity is forecast to be low in 3 years time (7.1%).